| BHR | Bolton–Hunter Reagent |
| CL | Chemiluminescence |
| DCC | N,N’-Dicyclohexylcarbodimide |
| DCFH-DA | Dichlorodihydrofluorescein Diacetate |
| DHE | Dihydroethidium |
| ECL | Enhanced Chemiluminescence |
| EGFR | Epidermal Growth Factor Receptor |
| FDA | Food and Drug Administration |
| GSH | Glutathione |
| Her/2 | Human Epidermal Growth Factor Receptor 2 |
| H2O2 | Hydrogen Peroxide |
| IC50 | 50% Inhibitory Concentration |
| mab(s) | Monoclonal Antibody(ies) |
| MTT | Tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| O2•− | Superoxide |
| ROS | Reactive Oxygen Species |
| Se | Selenium |
| SEM | Scanning Electron Microscope |
| Se-Tz | Seleno-Trastuzumab |
| SOD | Superoxide Dismutase |
| TB | Trypan Blue |
| THF | Tetrahydrofuran |
| Tz | Trastuzumab, Herceptin® |
| T-DM-1 | Kadcyla® |